MARATTO

article · Microbes and Infectious Diseases /Microbes and Infectious Diseases

Multidrug resistance and biofilm production among Staphylococcus aureus clinical isolates at a tertiary care hospital, Egypt.

20241 citationOpen accessZagazig University

Abstract

Staphylococcus aureus is a concerning issue due to multidrug resistance (MDR). This work aimed to detect the correlation between production of biofilm and resistance to antimicrobials among Staphylococcus aureus isolates. Methods: Out of 300 clinical specimens, 128 S. aureus were isolated, and their antibiotics susceptibility testing were analyzed by disc diffusion method. Their ability to form a biofilm was investigated by micro-titer plate (MTP) method. Finally, their biofilm production genes were determined by polymerase chain reaction. Results: 70% of isolates were multidrug resistant and 85% were methicillin resistant S. aureus (MRSA), while the least resistance was detected for linezolid, azithromycin and vancomycin (2%, 7% and 9%, respectively). Biofilm was detected phenotypically in 84.8% of isolates while biofilm genes were detected in 94.5% of isolates where ica A, ica B, ica C and ica D were detected in 91%, 92%, 70% and 90%, respectively. Multidrug resistance was more significantly determined in biofilm forming isolates than biofilm negative ones (p value<0.001). Conclusion: Biofilm producing S. aureus isolates were prevalent among patients admitted at Surgical Intensive Care Unit. They harbored biofilm genes like ica A, ica B, ica C and ica D and displayed high MDR pattern.

Research topics

  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Use and Resistance
  • Antifungal resistance and susceptibility

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/mid.2024.328410.2288

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.